Romano Steven J. 4
4 · Silence Therapeutics plc · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Romano Steven J.
EVP and Chief R&D Officer
Transactions
- Award
Employee Share Option (Right to Buy)
2025-01-02+285,000→ 285,000 totalExercise: $2.40Exp: 2035-01-02→ Ordinary Shares (285,000 underlying)
Footnotes (1)
- [F1]One fourth (1/4th) of the shares subject to the option shall vest on January 2, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.